🫀 Anxiety & Depression

Is Anxiety & Depression a normal emotion or does it require treatment?

Anxiety itself is a normal adaptive emotion that serves a protective function at low to moderate intensity. Treatment is warranted when anxiety intensity, frequency, or duration markedly exceeds the triggering context and causes significant distress or functional impairment—such as avoiding social situations or inability to work.

Which works better: anti-anxiety medication or CBT?

Research shows combined treatment yields optimal outcomes. SSRIs (e.g., sertraline, paroxetine) effectively reduce baseline anxiety levels, while CBT provides long-term coping skills and relapse prevention. Relapse rates after medication-only treatment are approximately 40-60%, significantly higher than patients who received CBT.

Why does deep breathing help with anxiety?

Anxiety activates the sympathetic nervous system (fight-or-flight), accelerating heart rate and shallow breathing. Deep diaphragmatic breathing—especially prolonged exhalation—stimulates the vagus nerve, triggering the parasympathetic system (rest-and-digest), lowering heart rate and blood pressure, and interrupting the physiological feedback loop of anxiety.

Does exposure therapy make anxiety worse?

Short-term discomfort may increase, but long-term outcomes are well-established. The key is the graded approach—starting with low-anxiety situations. Research confirms 80-90% of anxiety disorder patients show significant improvement after completing exposure therapy. Properly conducted, exposure enables safety learning: the feared outcome doesn't occur.

What's the difference between mindfulness and CBT?

CBT targets thought content—identifying and modifying distorted cognitions. Mindfulness cultivates a new relationship with thoughts and emotions—not changing content but transforming your attitude toward them. Modern therapy increasingly integrates both: CBT for cognitive flexibility, mindfulness for emotional acceptance.

How prevalent is Anxiety & Depression?

Clinically, Anxiety & Depression is very common—approximately 50-60% of patients with Major Depressive Disorder (MDD) also meet diagnostic criteria for an anxiety disorder, and vice versa. Comorbid patients typically experience more severe symptoms, longer illness duration, lower treatment response rates, and higher relapse rates. This is why clinical assessment must screen for both anxiety and depressive symptoms.

What is the first-line treatment for Anxiety & Depression?

The preferred treatment for comorbidity is SSRI antidepressants (sertraline, escitalopram, paroxetine), which are effective for both anxiety and depression. SNRIs (venlafaxine, duloxetine) are also first-line options. For psychotherapy, CBT has the strongest evidence base, but transdiagnostic "Unified Protocol"—addressing common core mechanisms across emotional disorders—is increasingly recommended, simultaneously targeting cognitive and behavioral patterns underlying both anxiety and depression.

How do patients with Anxiety & Depression choose between therapy approaches?

Treatment sequencing depends on dominant symptoms: if anxiety predominates (panic attacks, excessive worry), address anxiety first; if lack of motivation and anhedonia dominate, address depression first. CBT and ACT are effective for both. Note: some comorbid patients may feel more anxious during initial CBT behavioral activation homework—requiring the therapist to adjust pacing gradually.